Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

Go back to Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
(NASDAQ: KYMR) Delayed: 98.25 -1.2 (1.21%)
Previous Close $99.45    52 Week High
Open $97.77    52 Week Low
Day High $100.69    P/E N/A 
Day Low $94.62    EPS
Volume 1,368,159